Table 8.
Last purchase characteristics in Spain.
| Na | Number/volume purchased | Strengthb | Total price paid (€) | |
|---|---|---|---|---|
| Gabapentin | 45 | N: 45 Mean (STD): 5.8 (8.53) Median (IQR): 2.0 (1.0, 6.0) Range: (0.0, 33.0) |
N: 12 Mean (STD): 38.9 (49.44) Median (IQR): 8.0 (2.0, 100.0) Range: (1.0, 120.0) |
N: 45 Mean (STD): 14.4 (15.42) Median (IQR): 10.0 (2.0, 20.0) Range: (0.0, 55.0) |
| Pregabalin | 52 | N: 52 Mean (STD): 5.4 (7.65) Median (IQR): 2.0 (1.0, 6.0) Range: (0.0, 35.0) |
N: 16 Mean (STD): 26.3 (61.40) Median (IQR): 3.5 (2.0, 27.0) Range: (1.0, 250.0) |
N: 52 Mean (STD): 185,204.8 (1,302,466.10) Median (IQR): 10.0 (2.0, 32.0) Range: (0.0, 9,393,939.0) |
STD, Standard deviation; IQR, Interquartile Range.
a
Includes all survey respondents who report non-medical use of the product and “Bought it from a dealer” or “Bought it on the internet”.
b
Strength: MG per tablet/capsule, MCG/h per patch, MG per oral film, MG/ML per liquid, MCG per lollipop, MCG per lozenge, MG per suppository; All non-numeric entries were excluded.
Respondents have option to check ‘I'm not sure' under strength.